Cambrex

Cambrex is a leading global contract development and manufacturing organization (CDMO) providing end-to-end services across the entire pharmaceutical drug lifecycle. Founded in 1981 and headquartered in East Rutherford, New Jersey, Cambrex operates a global network of 14 locations across North America and Europe, employing a team of more than 2,000 scientists and manufacturing specialists. The company's core offerings span drug substance development and manufacturing — including custom API development, custom API manufacturing, generic API manufacturing (with over 70 approved generic APIs), and peptide development and manufacturing — as well as comprehensive drug product and analytical services covering method development, stability testing, microbiology, solid state chemistry, and formulation development. Cambrex's generic API manufacturing practice draws on more than 40 years of experience, with production sites in Italy, Sweden, and the USA. The company serves pharmaceutical and biotech customers from preclinical through commercial stages, positioning itself as a creative problem-solving partner that combines deep scientific expertise with a collaborative, customer-centric culture.